Douglas Lane & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $213K | Buy |
|
|||||
|
2025
Q2 | $210K | Sell |
|
|||||
|
2025
Q1 | $278K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $221K | Sell |
|
|||||
|
2023
Q3 | $206K | Sell |
|
|||||
|
2023
Q2 | $263K | Sell |
|
|||||
|
2023
Q1 | $309K | Buy |
|
|||||
|
2022
Q4 | $284K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $295K | Sell |
|
|||||
|
2021
Q3 | $285K | Buy |
|
|||||
|
2021
Q2 | $272K | Buy |
|
|||||
|
2021
Q1 | $246K | Sell |
|
|||||
|
2020
Q4 | $264K | Buy |
|
|||||
|
2020
Q3 | $273K | Sell |
|
|||||
|
2020
Q2 | $359K | Buy |
|
|||||
|
2020
Q1 | $314K | Buy |
|
|||||
|
2019
Q4 | $272K | Sell |
|
|||||
|
2019
Q3 | $292K | Sell |
|
|||||
|
2019
Q2 | $355K | Sell |
|
|||||
|
2019
Q1 | $713K | Buy |
|
|||||
|
2018
Q4 | $683K | Sell |
|
|||||
|
2018
Q3 | $983K | Buy |
|
|||||
|
2018
Q2 | $856K | Sell |
|
|||||
|
2018
Q1 | $929K | Buy |
|
|||||
|
2017
Q4 | $872K | Buy |
|
|||||
|
2017
Q3 | $950K | Buy |
|
|||||
|
2017
Q2 | $709K | Sell |
|
|||||
|
2017
Q1 | $706K | Buy |
|
|||||
|
2016
Q4 | $728K | Sell |
|
|||||
|
2016
Q3 | $898K | Sell |
|
|||||
|
2016
Q2 | $998K | Sell |
|
|||||
|
2016
Q1 | $1.2M | Buy |
|